The other three DPP-4 inhibitors, teneligliptin, anagliptin and trelagliptin, are only approved in the Japanese and Korean markets
Where the FDA approves these medications for adults with a BMI of 30, or a BMI of 27 with a weight-related comorbidity, the Bridge sets specific BMI thresholds paired with a defined list of qualifying conditions
The American College of Cardiology (ACC), American Heart Association (AHA), and Heart Failure Society of America (HFSA) recommend the use of SGLT-2 inhibitors in patients with heart failure, regardless of diabetes status
Although it is increasingly recognized as an important type of drought, its spatial and temporal characteristics over recent decades, as well as its impacts on regional hydrology in the basin, remain poorly understood
Between 2019 and 2023, the number of GLP-1 prescriptions increased by more than 400%, while spending increased by more than 500%